In this webinar, we’ll discuss what we know about FDA regulation of cannabis and cannabis-derived products and look at trends in recent FDA enforcement over CBD products.

Topics include:

• Pathways for FDA authorization of cannabis and other cannabis-derived products, including CBD
• New Drugs
• New Dietary Ingredient Notification – Foods/Dietary Supplements
• New Animal Foods/Drugs
• What other cannabinoids are of commercial interest
• Other legal concerns around marketing cannabinoids

Speakers:

• Heather Hatcher, Ph.D., Regulatory Scientist, Womble Bond Dickinson (US) LLP
• Mark Vaders, Associate, Womble Bond Dickinson (US) LLP

CPD points 1.00 General credit hour pending in CA/DE/GA/NC/SC/TX/VA